Register for Your Free Live Webinar Now:

"Patients, Pipeline & Promise: Software-Enhanced Drugs"

Join Anthony Costello, Medidata CEO, and David Benshoof Klein, Click Therapeutics Founder and CEO, to discuss why now is the time to embrace software-enhanced (SE) drugs.

Software-Enhanced (SE) drugs open new pipelines of opportunity, and allow forward-looking leaders to differentiate their portfolios. Be among the vanguard to understand and implement this transformative approach. Learn how you can become an expert on a topic poised to redefine patient care.

Join Anthony Costello, Medidata CEO, and David Benshoof Klein, Click Therapeutics Founder and CEO, to discuss why now is the time to embrace software-enhanced (SE) drugs.

Key takeaways:

• Leave with a better understanding of digital therapeutics and software-enhanced drugs
• How you can deliver better patient experiences and safer, more effective care
• How specific therapeutic areas like oncology and cardiometabolics can leverage SE drugs to significantly improve care
• How Click's expertise in software-enhanced drugs, Medidata's leading position in clinical trial technology and the combined partnership can help you innovate and boost your pipeline

Offered Free by: Medidata
See All Resources from: Medidata